These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H. Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684 [Abstract] [Full Text] [Related]
3. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review. Wang X, Wang P, Wang A, Xu Y, Wang L, Chen Z. BMC Infect Dis; 2021 Jan 06; 21(1):17. PubMed ID: 33407199 [Abstract] [Full Text] [Related]
8. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases. Liu Y, Ma C, Wang G, Wang L. J Am Acad Dermatol; 2019 Aug 06; 81(2):534-540. PubMed ID: 30654082 [Abstract] [Full Text] [Related]
11. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population. López de Cáceres CVB, Rodrigues-Fernandes CI, Rendón Henao J, Morais TML, Soares CD, de Almeida OP, Fonseca FP, Delgado-Azañero W. J Oral Pathol Med; 2021 Jul 06; 50(6):530-539. PubMed ID: 34097774 [Abstract] [Full Text] [Related]
12. Hydroa vacciniforme-like lymphoproliferative disorder: a retrospective cohort study of seven pediatric cases. Ren F, Zhu J, Perry DM, Pruitt L, Elston DM. Int J Dermatol; 2020 Aug 06; 59(8):e290-e292. PubMed ID: 32403170 [No Abstract] [Full Text] [Related]
13. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review. Kim YJ, Yang HJ, Won CH, Chang SE, Lee MW, Lee WJ. Dermatology; 2023 Aug 06; 239(5):700-711. PubMed ID: 37231869 [Abstract] [Full Text] [Related]
14. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases. Zhang Y, Liu Y, Xu J, Liang Y, Xu Z. Eur J Dermatol; 2024 Apr 01; 34(2):144-149. PubMed ID: 38907544 [Abstract] [Full Text] [Related]
15. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection. Chen CC, Chang KC, Medeiros LJ, Lee JY. Int J Mol Sci; 2020 Dec 07; 21(23):. PubMed ID: 33297336 [Abstract] [Full Text] [Related]
16. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Quintanilla-Martinez L, Ridaura C, Nagl F, Sáez-de-Ocariz M, Durán-McKinster C, Ruiz-Maldonado R, Alderete G, Grube P, Lome-Maldonado C, Bonzheim I, Fend F. Blood; 2013 Oct 31; 122(18):3101-10. PubMed ID: 23982171 [Abstract] [Full Text] [Related]
17. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Plaza JA, Sangueza M. Am J Dermatopathol; 2015 Jan 31; 37(1):20-5. PubMed ID: 25162933 [Abstract] [Full Text] [Related]
19. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy. İmren IG, Demirkan N, Çomut E, Duygulu Ş. Int J Dermatol; 2020 Dec 31; 59(12):e452-e454. PubMed ID: 32808321 [No Abstract] [Full Text] [Related]
20. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases. Long V, Liang MW, Tan SH. Int J Dermatol; 2018 Nov 31; 57(11):1283-1292. PubMed ID: 29926891 [Abstract] [Full Text] [Related] Page: [Next] [New Search]